Catalyst Pharmaceuticals PE Ratio 2006-2019 | CPRX

Current and historical p/e ratio for Catalyst Pharmaceuticals (CPRX) from 2006 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Catalyst Pharmaceuticals PE ratio as of January 28, 2020 is 53.50.
Catalyst Pharmaceuticals PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2020-01-28 4.28 53.50
2019-09-30 5.31 $0.08 66.38
2019-06-30 3.84 $-0.13 0.00
2019-03-31 5.10 $-0.29 0.00
2018-12-31 1.92 $-0.34 0.00
2018-09-30 3.78 $-0.26 0.00
2018-06-30 3.12 $-0.23 0.00
2018-03-31 2.39 $-0.22 0.00
2017-12-31 3.91 $-0.22 0.00
2017-09-30 2.52 $-0.21 0.00
2017-06-30 2.76 $-0.21 0.00
2017-03-31 1.95 $-0.22 0.00
2016-12-31 1.05 $-0.23 0.00
2016-09-30 1.09 $-0.25 0.00
2016-06-30 0.71 $-0.25 0.00
2016-03-31 1.17 $-0.25 0.00
2015-12-31 2.45 $-0.25 0.00
2015-09-30 3.00 $-0.23 0.00
2015-06-30 4.13 $-0.25 0.00
2015-03-31 4.33 $-0.24 0.00
2014-12-31 2.97 $-0.24 0.00
2014-09-30 3.32 $-0.22 0.00
2014-06-30 2.53 $-0.28 0.00
2014-03-31 2.26 $-0.31 0.00
2013-12-31 1.95 $-0.28 0.00
2013-09-30 3.05 $-0.25 0.00
2013-06-30 0.90 $-0.20 0.00
2013-03-31 0.49 $-0.13 0.00
2012-12-31 0.44 $-0.13 0.00
2012-09-30 1.51 $-0.23 0.00
2012-06-30 0.53 $-0.20 0.00
2012-03-31 1.11 $-0.25 0.00
2011-12-31 1.29 $-0.29 0.00
2011-09-30 1.49 $-0.23 0.00
2011-06-30 1.88 $-0.23 0.00
2011-03-31 1.12 $-0.24 0.00
2010-12-31 0.99 $-0.22 0.00
2010-09-30 1.12 $-0.24 0.00
2010-06-30 0.99 $-0.28 0.00
2010-03-31 0.80 $-0.34 0.00
2009-12-31 0.63 $-0.50 0.00
2009-09-30 0.84 $-0.71 0.00
2009-06-30 0.65 $-0.84 0.00
2009-03-31 1.70 $-0.90 0.00
2008-12-31 1.80 $-0.81 0.00
2008-09-30 2.98 $-0.61 0.00
2008-06-30 3.49 $-0.45 0.00
2008-03-31 3.75 $-0.36 0.00
2007-12-31 3.45 $-0.33 0.00
2007-09-30 3.20 $-0.33 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.441B $0.001B
Catalyst Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases, including Lambert-Eaton myasthenic syndrome (LEMS), anti-MuSK antibody positive myasthenia gravis (MuSK-MG), congenital myasthenic syndromes (CMS), and spinal muscular atrophy (SMA) Type 3.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $65.853B 39.39
Takeda Pharmaceutical (TAK) Japan $61.657B 9.74
Astellas Pharma (ALPMY) Japan $32.762B 16.36
Eisai (ESALY) Japan $21.718B 41.87
Merck (MKGAF) Germany $16.911B 23.08
Grifols, S.A (GRFS) Spain $15.848B 20.77
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
Neurocrine Biosciences (NBIX) United States $9.356B 441.70
Catalent (CTLT) United States $9.210B 37.47
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.449B 0.00
Ionis Pharmaceuticals (IONS) United States $8.427B 17.07
Jazz Pharmaceuticals (JAZZ) Ireland $8.260B 10.55
IPSEN SA ADR (IPSEY) France $6.010B 0.00
STADA ARZNEIMI (STDAF) Germany $5.972B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.540B 0.00
Hypermarcas (HYPMY) Brazil $5.095B 15.50
Arrowhead Pharmaceuticals (ARWR) United States $4.345B 65.80
United Therapeutics (UTHR) United States $4.090B 0.00
Evotec AG (EVTCY) Germany $4.074B 65.85
FibroGen (FGEN) United States $3.658B 107.51
Nektar Therapeutics (NKTR) United States $3.584B 0.00
Sage Therapeutics (SAGE) United States $3.557B 0.00
PTC Therapeutics (PTCT) United States $3.176B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.160B 11.63
ChemoCentryx (CCXI) United States $2.390B 0.00
Zogenix (ZGNX) United States $2.235B 0.00
Heron Therapeutics (HRTX) United States $2.138B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.075B 0.00
Tilray (TLRY) Canada $1.963B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.941B 61.90
Xencor (XNCR) United States $1.916B 58.24
Pacira Pharmaceuticals (PCRX) United States $1.814B 53.65
Theravance Biopharma (TBPH) Cayman Islands $1.544B 0.00
Corcept Therapeutics (CORT) United States $1.536B 18.67
CLINIGEN GP (CLIGF) United Kingdom $1.506B 0.00
USANA Health Sciences (USNA) United States $1.409B 15.03
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.406B 9.59
Endo (ENDP) Ireland $1.281B 2.35
Enanta Pharmaceuticals (ENTA) United States $1.074B 24.41
Karyopharm Therapeutics (KPTI) United States $1.066B 0.00
Dermira (DERM) United States $1.025B 0.00
Portola Pharmaceuticals (PTLA) United States $1.020B 0.00
Aerie Pharmaceuticals (AERI) United States $0.997B 0.00
Akebia Therapeutics (AKBA) United States $0.931B 0.00
Radius Health (RDUS) United States $0.897B 0.00
ImmunoGen (IMGN) United States $0.706B 0.00
Collegium Pharmaceutical (COLL) United States $0.699B 0.00
TherapeuticsMD (TXMD) United States $0.683B 0.00
Flexion Therapeutics (FLXN) United States $0.676B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.543B 0.00
Molecular Templates (MTEM) United States $0.516B 0.00
Ardelyx (ARDX) United States $0.480B 0.00
Translate Bio (TBIO) United States $0.471B 0.00
Organogenesis Holdings (ORGO) United States $0.450B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.441B 0.00
Innate Pharma SA (IPHYF) France $0.432B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.431B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.425B 18.34
Aptorum Group (APM) Hong Kong, SAR China $0.424B 0.00
Siga Technologies (SIGA) United States $0.422B 9.63
Rigel Pharmaceuticals (RIGL) United States $0.417B 0.00
DURECT (DRRX) United States $0.385B 0.00
Recro Pharma (REPH) United States $0.373B 0.00
OptiNose (OPTN) United States $0.365B 0.00
Harpoon Therapeutics (HARP) United States $0.360B 0.00
Indivior (INVVY) United States $0.355B 1.28
Lannett Co Inc (LCI) United States $0.355B 4.13
Calithera Biosciences (CALA) United States $0.353B 0.00
Rafael Holdings (RFL) United States $0.320B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.295B 0.00
KalVista Pharmaceuticals (KALV) United States $0.294B 0.00
Concert Pharmaceuticals (CNCE) United States $0.260B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.257B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.245B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.242B 0.00
MEI Pharma (MEIP) United States $0.235B 0.00
Jounce Therapeutics (JNCE) United States $0.225B 3.00
IMV INC (IMV) Canada $0.224B 0.00
Ocular Therapeutix (OCUL) United States $0.213B 0.00
Nature's Sunshine Products (NATR) United States $0.192B 33.07
La Jolla Pharmaceutical (LJPC) United States $0.190B 0.00
Taiwan Liposome (TLC) Taiwan $0.170B 0.00
Xeris Pharmaceuticals (XERS) United States $0.165B 0.00
CannTrust Holdings (CTST) Canada $0.160B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.141B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.128B 0.00
Redhill Biopharma (RDHL) Israel $0.125B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.122B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.109B 0.00
CV Sciences (CVSI) United States $0.108B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Aquestive Therapeutics (AQST) United States $0.102B 0.00
Otonomy (OTIC) United States $0.100B 0.00
Champions Oncology (CSBR) United States $0.095B 0.00
PolarityTE (PTE) United States $0.091B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.090B 0.00
Neos Therapeutics (NEOS) United States $0.089B 0.00
MediWound (MDWD) Israel $0.083B 0.00
Infinity Pharmaceuticals (INFI) United States $0.082B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.076B 22.69
RENEURON GP (RNUGF) United Kingdom $0.074B 0.00
CTI BioPharma (CTIC) United States $0.071B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.070B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.065B 0.00
AgeX Therapeutics (AGE) United States $0.064B 0.00
Natural Alternatives (NAII) United States $0.062B 15.36
IsoRay (ISR) United States $0.060B 0.00
Aclaris Therapeutics (ACRS) United States $0.059B 0.00
SCYNEXIS (SCYX) United States $0.055B 0.00
Nivalis Therapeutics (ALPN) United States $0.054B 0.00
Onconova Therapeutics (ONTX) United States $0.053B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.051B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.047B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.047B 0.00
Forward Pharma (FWP) Denmark $0.044B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.042B 0.00
VAXART, INC (VXRT) United States $0.042B 0.00
Jaguar Animal Health (JAGX) United States $0.039B 0.00
ElectroCore (ECOR) United States $0.037B 0.00
Mannatechorporated (MTEX) United States $0.037B 0.00
Iterum Therapeutics (ITRM) Ireland $0.035B 0.00
Biomerica (BMRA) United States $0.030B 0.00
PharmAthene (ALT) United States $0.028B 0.00
India Globalization Capital (IGC) United States $0.026B 0.00
China SXT Pharmaceuticals (SXTC) China $0.026B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.025B 0.00
ProPhase Labs (PRPH) United States $0.023B 0.00
Regulus Therapeutics (RGLS) United States $0.023B 0.00
Bio-Path Holdings (BPTH) United States $0.020B 0.00
Novan (NOVN) United States $0.018B 0.00
Cardiome Pharma (CORV) Canada $0.018B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.017B 0.00
Shineco (TYHT) China $0.016B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.015B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Vical (BBI) United States $0.012B 0.00
Lipocine (LPCN) United States $0.012B 0.00
Flex Pharma (SLRX) United States $0.011B 0.00
Heat Biologics (HTBX) United States $0.009B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.009B 0.00
HANCOCK JAFFE (HJLI) United States $0.009B 0.00
Hemispherx BioPharma (AIM) United States $0.008B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.008B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.007B 0.00
RXi Pharmaceuticals (PHIO) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00